Commit To Purchase Amphenol At $90, Earn 11.2% Annualized Using Options

Investors eyeing a purchase of Amphenol Corp. ( APH) shares, but cautious about paying the going market price of $92.24/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $90 strike, which has a bid at the time of this writing of $2.85. Collecting that bid as the premium represents a 3.2% return against the $90 commitment, or a 11.2% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to APH's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $90 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Amphenol Corp. sees its shares fall 2.2% and the contract is exercised (resulting in a cost basis of $87.15 per share before broker commissions, subtracting the $2.85 from $90), the only upside to the put seller is from collecting that premium for the 11.2% annualized rate of return.

Interestingly, that annualized 11.2% figure actually exceeds the 0.9% annualized dividend paid by Amphenol Corp. by 10.3%, based on the current share price of $92.24. And yet, if an investor was to buy the stock at the going market price in order to collect the dividend, there is greater downside because the stock would have to lose 2.21% to reach the $90 strike price.

If you liked this article you might like

Cramer: These Sectors Look Bullish (Part II)

Cramer: There Are Powerful Themes in Several Bull Markets

Tesla Shares Rise Even as Elon Musk Dismisses Governance Concerns

Amphenol Is a Great Tech Stock to Buy Now

The Canadian Cannabis Market Has a 'Lot of Room to Run'